Insider tradingForm 4
Outlook Therapeutics, Inc. (OTLK) Insider Trading
3 open-market trades reported since Aug 14, 2026: 3 purchases worth $2.50M and 0 sales worth $0.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Ghiath M. Sukhtian | Director | 1 | $2.50M | 0 | $0 |
| Robert Charles Jahr | CEO | 1 | $0 | 0 | $0 |
| Lawrence A. Kenyon | CFO | 1 | $0 | 0 | $0 |
ADVERTISEMENT
320 × 100 ad slot
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Aug 14 | Ghiath M. SukhtianDirector | ▲ BUY | $2.50M | |
| Aug 14 | Robert Charles JahrCEO | ▲ BUY | n/a | |
| Aug 14 | Lawrence A. KenyonCFO | ▲ BUY | n/a |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings